Institute for Evolutionary Sciences, Montpellier University, Montpellier, France; the School of Anthropology and Museum Ethnography, University of Oxford, Oxford, United Kingdom; the Department of Obstetrics and Gynecology, Oregon Health & Science University, and the OHSU-PSU School of Public Health, Portland, Oregon; the National Institute of Public Health (INSP), Center for Population Health (CISP), Cuernavaca, Morelos, Mexico; and Clue by BioWink GmbH, Berlin, Germany.
Obstet Gynecol. 2024 Jan 1;143(1):83-91. doi: 10.1097/AOG.0000000000005343. Epub 2023 Aug 10.
To assess whether coronavirus disease 2019 (COVID-19) is associated with menstrual cycle length changes and, if so, how that compares with those undergoing vaccination or no event (control).
We conducted a retrospective cohort analysis in which we analyzed prospectively tracked cycle-length data from users of a period tracker application who also responded to a survey regarding COVID-19 symptoms and vaccination. We restricted our sample to users aged 16-45 years, with normal cycle lengths (24-38 days) and regular tracking behavior during the five cycles around COVID-19 symptoms or vaccination or a similar time period for those experiencing no event (control group). We calculated the within-user change in cycle length (days) from the three consecutive cycles preevent average (either vaccination, disease, or neither; cycles 1-3) to the event (cycle 4) and postevent (cycle 5) cycles. We used mixed-effects models to estimate the age- and country-adjusted difference in change in cycle length across the groups.
We included 6,514 users from 110 countries representing 32,570 cycles (COVID-19 symptoms: 1,450; COVID-19 vaccination: 4,643; control: 421). The COVID-19 cohort experienced a 1.45-day adjusted increase in cycle length during cycle 4 (COVID-19) compared with their three preevent cycles (95% CI 0.86-2.04). The vaccinated group experienced a 1.14-day adjusted increase in cycle length during cycle 4 (COVID-19 vaccine) compared with their preevent average (95% CI 0.60-1.69). The control group (neither vaccine nor disease) experienced a 0.68-day decrease (95% CI -1.18 to -0.19) in a similar time period. Post hoc tests showed no significant differences in the magnitude of changes between the COVID-19 and vaccination cohorts. In both cohorts, cycle length changes disappeared in the postevent cycle.
Experiencing COVID-19 is associated with a small change in cycle length similar to COVID-19 vaccination. These changes resolve quickly within the next cycle.
评估 2019 年冠状病毒病(COVID-19)是否与月经周期长度变化有关,如果是,与接种疫苗或无事件(对照组)相比如何。
我们进行了一项回顾性队列分析,分析了使用经期跟踪应用程序的用户前瞻性跟踪的周期长度数据,这些用户还回答了关于 COVID-19 症状和疫苗接种的调查。我们将样本限制在年龄在 16-45 岁、周期长度正常(24-38 天)且在 COVID-19 症状或疫苗接种前后五个周期或无事件(对照组)期间有规律的跟踪行为的用户。我们计算了从三个连续周期的前三个周期(接种疫苗、疾病或两者都没有;周期 1-3)到事件(周期 4)和事件后(周期 5)周期的周期长度(天数)的个体内变化。我们使用混合效应模型来估计各组之间的周期长度变化的年龄和国家调整差异。
我们纳入了来自 110 个国家的 6514 名用户,共 32570 个周期(COVID-19 症状:1450;COVID-19 疫苗接种:4643;对照组:421)。与前三个周期相比,COVID-19 组在第 4 周期(COVID-19)的周期长度增加了 1.45 天,调整后差异为 0.86-2.04。与前三个周期相比,接种疫苗组在第 4 周期(COVID-19 疫苗)的周期长度增加了 1.14 天,调整后差异为 0.60-1.69。对照组(既无疫苗也无疾病)在类似时间内周期长度减少了 0.68 天(95%CI-1.18 至-0.19)。事后检验表明,COVID-19 组和疫苗接种组的变化幅度无显著差异。在两个队列中,周期长度变化在后续周期中消失。
感染 COVID-19 与月经周期长度的微小变化有关,与 COVID-19 疫苗接种相似。这些变化在接下来的周期内迅速解决。